Osteomalacia was induced in rats fed a diet containing 50,000 ppm (5%) iron lactate for 13 weeks. The histopathology and histomorphometrical dynamics of osteoblasts under this condition were examined. Bone histomorphometry of the proximal tibial metaphysis revealed that the osteoblast surface, osteoid volume, osteoid surface and labeled surface ratio, which are the parameters of bone formation had increased. The blood chemistry revealed the greatest elevation in the osteocalcin level; however, the parathyroid hormone (PTH) secretion and inorganic phosphorus level were very low. From the serum biochemical, histopathological and histomorphometrical findings, the bone lesion in iron lactate-overloaded rats was considered to be similar to low turnover osteomalacia showing decreased trabeculae in secondary spongiosa and increased lamellar osteoid. Furthermore, an iron-positive reaction was detected at the interface between osteoid and mineralized bone. In the bone lesions induced by chronic iron overload, osteoblast recruitment exceeded that of mineralization or, alternatively, the iron within osteoblasts along the trabecular bone suppressed the remodeling and led to an increase in osteoid thickness.
Barsotti G., Cupisti A., Morelli E., Meola M., Cozza V., Barsotti M., Giovannetti S. (1998). Secondary hyperparathyroidism in severe chronic renal failure is corrected by very-low dietary phosphate intake and calcium carbonate supplementation. Nephron79: 137—141.
2.
Brent GA, Leboff MS, Seely EW, Conlin PR, Brown EM (1988). Relationship between the concentration and rate of change of calcium and serum intact parathyroid hormone levels in nomal humans. J Clin Endocrinol Metab67: 944—950.
3.
Brown EM (1991). Extracellular calcium sensing, regulation of parathyroid cell function, and role of calcium and other irons as extracellular (first) messengers. Physiol Rwv71: 371—411.
4.
Brown EM, Thatcher JG, Watson EJ, Leombruno R. (1984). Extracellular calcium potentates the inhibitory effects of magnesium on parathyroid function in dispersed bovine parathyroid cells. Metabolism33: 171—176.
5.
Chen C., Ansat CS, Posillico JT, Brown EM (1987). Effect of extracellular calcium and magnesium on cytosolic calcium concentrations in fura-2-loaded bovine parathyroid cells . J Bone Min Res2: 319—327.
6.
Ebina Y., Okada S., Hamazaki S., Tada Y., Midorikawa O. (1991). Impairment of bone formation with aluminum and ferric nitrilotriacetate complexes. Calcif Tissue Int48: 28—36.
7.
Felsenfeld AJ , Llach F. (1993). Parathyroid gland function in chronic renal failure. Kidney Int43: 771—789.
8.
Fournier A., Moriniere P., Cohen-Solar M., Boudailliez B., Achard J., Marie A., Sebert J. (1991). Adynamic bone disease in uremia: may it be idiopathic? Is it an actual diseases. Nephron58: 1—12.
9.
Hayman AR, Cox TM (1994). Purple acid phosphatase of the human macrophage and osteoclast. Characterization, molecular properties, and crystallization of the recombinant di-iron-oxo protein secreted by baculovirus-infected insect cells. J Biol Chem14: 1294—1300.
10.
Hodsman AB, Sherrard DJ, Alfrey AC, Ott S., Brickman AS, Miller ML, Maloney NA, Coburn JW (1982). Bone aluminum and histomorphometric features of renal osteodystrophy. J Clin Endocrinol Metab54: 539—546.
11.
Kawabata T. , Shimokawa I., Tomita M., Hirano T., Shindo H. (2002). Effects of caloric restriction on development of the proximal growth plate and metaphysic of the caput femoris in spontaneously hypertensive rats: microscopic and computer-assisted image analysis. Microsc Res Tech15: 306— 312.
12.
Levin S., Semler D., Ruben Z. (1993). Effects of two weeks of feed restriction on some common toxicologic parameters in Sprague-Dawley rats. Toxicol Pathol21: 1—14.
13.
Lorenzo V., Martín M., Rufino M., Jiménez A., Malo AM, Sanchez E., Hernández D, Rodríguez, Torres A (2001). Protein intake, control of serum phosphorus, and relatively low levels of parathyroid hormone in elderly hemodialysis patients. Am J Kidney Dis37: 1260—1266.
14.
Malluche HH , Faugere MC (1988). Aluminum-related bone disease. Blood Purif1: 1—15.
15.
Matsushima S., Hoshimoto M., Torii M., Ozaki K, Narama (2001). Iron lactate-induced osteopenia in male Sprague-Dawley rats. Toxicol Pathol29: 623—629.
16.
Narama I., Ozaki K., Matsushima S., Matsuura T. (1999). Eosinophilic gastroenterocolitis in iron lactate-overload rats. Toxicol Pathol27: 318—324.
17.
Narama I., Ozaki K., Matsuura T., Maruyama H. (1999). Topographic relation between iron-deposition and cytotoxic changes in iron lactate-overloaded rats. J Toxicol Pathol12: 105—111.
18.
Ott SM, Feist E., Andress DL, Liu CC, Sherrard DJ, Alfrey AC, Slatopolsky E., Howard GA (1987). Development and reversibility of aluminum-induced bone lesion in the rat. J Lab Clin Med109: 40—47.
19.
Parfitt AM (1983). The stereologic basis of bone histomorphometry. Theory of quantitative microscopy and reconstruction of the third dimension . In: Bone Histomorphometry. Techniques and Interpretations , Recker R (ed). CRC Press, Boca Raton, pp 53—87.
20.
Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H., Meunier PJ, Ott SM, Recker RR (1987). Bone histomorphometry: standardization of nomenclature, symbols, and units. J Bone Min Res2: 595—611.
21.
Parfitt AM, Mathews CHE, Villanueva AR, Kleerekoper M., Frame B., Rao DS (1983). Relationship between surface volume and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest72: 1396— 1409.
22.
Parisien M. , Charhon SA, Arlot M., Mainetti E., Chavassieux P., Chapuy MC, Meunier PJ (1988). Evidence for a toxic effect of aluminum on osteoblasts: a histomorhometric study in hemodialysis patients with aplastic bone disease. J Bone Miner Res3: 259—267.
23.
Posner AS, Blumenthal NC, Boskey AL (1986). Model of aluminum-induced osteomalacia: inhibition of apatite formation and growth. Kindey Int Suppl18: 17—19.
24.
Sato K., Nohtomi K., Demura H., Takeuchi A., Kobayashi T., Kazama J., Ozawa H. (1997). Saccharated ferric oxide (SFO)-induced osteomalacia: in vitro inhibition by SFO of bone formation and 1,25-dihydroxy-vitamin D production in renal tubules. Bone21: 57—64.
25.
Woods CG (1994). Metabolic bone diseases. In: Diseases of Bone and Joints, Salisbury JR (ed). Chapman & Hall Medical, pp 236—285.
26.
Yukihiro S. , Okada S., Takeuchi K., Inoue H. (1995). Experimental osteodystrophy of chronic renal failure induced by aluminum- and ferric-nitrilotriacetate in wister rats. Pathol Int45: 19—25.
